Pyridinium cross-links in multiple myeloma: Correlation with clinical parameters and use for monitoring of intravenous clodronate therapy—A pilot study of the German Myeloma Treatment Group (GMTG)

This publication has 24 references indexed in Scilit:

• A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group
  European Journal Of Cancer, 1995
• Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma
  Bone, 1994
• Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.
  Journal of Clinical Investigation, 1993
• Biochemical Markers of Bone Metabolism
  Annals of Medicine, 1993
• Prognostic value of clinical, laboratory, and histological characteristics in multiple myeloma: Improved definition of risk groups
  European Journal Of Cancer, 1993
• Bisphosphonates
  Drugs, 1991
• LONG-TERM EFFECTS OF PARENTERAL DICHLOROMETHYLENE BISPHOSPHONATE (CL2MBP) ON BONE DISEASE OF MYELOMA PATIENTS TREATED WITH CHEMOTHERAPY
  Hematological Oncology, 1990
• Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma Cells
  New England Journal of Medicine, 1987
• Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma
  Metabolic Bone Disease and Related Research, 1982
• Effects of Dichloromethylene Diphosphonate on Skeletal Mobilization of Calcium in Multiple Myeloma
  New England Journal of Medicine, 1980